ZANTE GREG (Chief Financial Officer) sold 23.3% of their position (50.31K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.15M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+44.53K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
+21.67K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−45.61K
Price / share
$42.69
Trade value
$1.95M
% of position
Common Stock, par value $0.00001 per share
Shares
−4.70K
Price / share
$43.32
Trade value
$203.60K
% of position
Net shares
+15.89K
Net value
-$2.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 1/3/2025 | A · Award | +44.53K | — | — | 29.8% | 149.37K | 193.90K |
| Common Stock, par value $0.00001 per share Direct | 1/3/2025 | A · Award | +21.67K | — | — | 11.2% | 193.90K | 215.57K |
| Common Stock, par value $0.00001 per share Direct | 1/6/2025 | S · Sale | −45.61K | $42.69 | $1.95M | 21.2% | 215.57K | 169.96K |
| Common Stock, par value $0.00001 per share Direct | 1/6/2025 | S · Sale | −4.70K | $43.32 | $203.60K | 2.8% | 169.96K | 165.26K |
| Total | +15.89K | -$2.15M | ||||||
Stock Option (Right to Buy)
Common Stock
37.20K shares
Shares
+37.20K
Strike price
42.89
Held after
37.20K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock37.20K shares | 1/3/2025 | A · Award | +37.20K | 42.89 | — | 37.20K |